Ehab joined Akoya Biosciences as Chief Medical Officer (CMO) in April 2022 to lead our strategy in advancing the use of our spatial phenotyping solutions in the clinical setting. Dr. El-Gabry brings a wealth of experiences critical to our vision of advancing spatial phenotyping in precision medicine and cancer care. He is a board-certified pathologist …
Marilee joined Akoya Biosciences as Chief People Officer in January 2022, bringing deep operational and strategic expertise in managing human resources for rapidly growing life sciences companies. She has more than 30 years of HR leadership, having worked at life sciences and technology companies ranging from start-ups to international, public companies. Prior to joining Akoya, …
Elliot joined Akoya Biosciences in September 2021 as Vice President, Product and Portfolio Management. He brings over 15 years of experience in the life sciences industry. Most recently, Elliot held the role of Senior Director & General Manager at Thermo Fisher Scientific, where he managed a portfolio of genomics products. Elliot earned his Bachelor of …
Pascal joined Akoya Biosciences in October 2021 in the role of Senior Vice President, Research and Development and Laboratory Operations. He possesses deep scientific and operational experience leading teams in developing and implementing successful and innovative products through international regulatory agencies to customers and patients worldwide. Prior to joining Akoya, he served as Senior Vice …
Gavin joined Akoya in July of 2020 to lead business and market development activities with the goal of establishing Akoya platforms in clinical markets. Prior to Akoya, Gavin was VP, Commercial Operations at Fluidigm, where he held multiple global roles including establishing pharma strategic alliances and developing the translational research market for high parameter immunohistochemistry. …
Paul joined Akoya in January of 2018 as the head of sales. He has over 20 years of experience in customer support, marketing, and sales leadership roles. Paul has most recently led large commercial sales teams at both Thermo Fisher Scientific and Bio-Rad Laboratories focused in both the Life Science and Clinical industry respectively. Paul …
Prior to joining Akoya Biosciences, Cliff was Director of Applications and Services for PerkinElmer’s Quantitative Pathology Business Unit. Cliff was co-founder and CTO of CRI, Inc., acquired by PerkinElmer in 2011. Since then, as Oncology Fellow, Cliff lead development of multiplexed staining methods (Opal), built the contract research business, partnered with pharma and academia to …
Dr. Julia Kennedy-Darling joined Akoya in March of 2017 to lead development efforts for the CODEX technology. Prior to joining Akoya, Julia was a co-inventor of the CODEX technology while a Cancer Research Institute Irvington Postdoctoral Fellow in Professor Garry Nolan’s lab at Stanford University School of Medicine. She received her Ph.D. in Chemistry from …
Prior to joining Akoya Biosciences, Peter was Director of R&D for PerkinElmer’s Quantitative Pathology Business Unit. Peter was a co-founder of CRI, Inc., where he was responsible for product development, technology assessment, licensing, and intellectual property management. He has been a Principal Investigator on NSF, NASA, and Air Force grants; is a named inventor on …
Frederic joined Akoya Biosciences in April 2021 to serve as the Chief Operating Officer. He brings over 25 years of experience in launching and managing global businesses in the life sciences and healthcare industries. Most recently, he served as Chief Operating Officer at the Parker Institute for Cancer Immunotherapy (PICI). Prior to PICI, he served …
Sign up to receive our eNewsletter, new product updates, events, and more!
